Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sonoma Pharmaceuticals (SNOA) Return on Invested Capital (2016 - 2025)

Sonoma Pharmaceuticals has reported Return on Invested Capital over the past 9 years, most recently at 0.01% for Q4 2025.

  • For Q4 2025, Return on Invested Capital changed 0.0% year-over-year to 0.01%; the TTM value through Dec 2025 reached 0.01%, changed 0.0%, while the annual FY2025 figure was 0.01%, 0.0% changed from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.01% at Sonoma Pharmaceuticals, up from 0.01% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.0% in Q1 2021 and troughed at 0.01% in Q4 2022.
  • A 5-year average of 0.01% and a median of 0.01% in 2022 define the central range for Return on Invested Capital.
  • Biggest five-year swings in Return on Invested Capital: changed 0bps in 2021 and later fell -1bps in 2022.
  • Year by year, Return on Invested Capital stood at 0.01% in 2021, then tumbled by -93bps to 0.01% in 2022, then soared by 36bps to 0.01% in 2023, then decreased by -24bps to 0.01% in 2024, then rose by 14bps to 0.01% in 2025.
  • Business Quant data shows Return on Invested Capital for SNOA at 0.01% in Q4 2025, 0.01% in Q3 2025, and 0.01% in Q2 2025.